Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies

Tumor-infiltrating lymphocytes (TILs) have potential value for stratifying the treatment of breast cancer (BC), though their precise use remains unclear. We aimed to investigate the utility of TILs using an alternative approach in different settings. We reviewed patients with triple-negative (TN) or...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Breast Cancer Res Treat
Hlavní autoři: Hida, Akira I., Sagara, Yasuaki, Yotsumoto, Daisuke, Kanemitsu, Shuichi, Kawano, Junko, Baba, Shinichi, Rai, Yoshiaki, Oshiro, Yumi, Aogi, Kenjiro, Sagara, Yoshiaki, Ohi, Yasuyo
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer US 2016
Témata:
Preclinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4937092/
https://ncbi.nlm.nih.gov/pubmed/27260189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3848-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky